Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BLODSJEKK AS
AS
Active
Org 924519584
Baglergaten 3, 3111 Tønsberg
General medical practice activities · NACE 8621
Est. 2020
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 1,3M
+36% vs 2023
EBITDA margin
9.6%
-41% vs 2023
Equity ratio
46.4%
Financial strength
Net profit 2024
NOK 93K
-41% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 1,3M
+36%
EBITDA
NOK 120K
-41%
Net profit
NOK 93K
-41%
Total assets
NOK 794K
+20%
Equity
NOK 368K
+34%
Employees
0
—
Company information
Legal name
BLODSJEKK AS
Org number
924519584
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
30. januar 2020
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Legetjenester.
Contact
Address
Baglergaten 3, 3111 Tønsberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Tønsberg
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
1M
2023
1M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
63
252
491
925
1 259
Staff expenses
−0
−0
−0
−0
−0
EBITDA
63
−164
213
204
120
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
63
−164
213
204
120
Net financials
0
−0
−0
−1
−1
Profit before tax
63
−165
213
203
120
Tax
14
−0
11
45
26
Net profit
49
−165
202
158
93
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
93
96
423
662
794
Equity
79
−86
117
275
368
Long-term debt
0
0
0
0
0
Short-term debt
14
182
306
387
426
Total debt
14
182
306
387
426
Financial ratios
5-year trend
EBITDA margin
9.6%
This company
15.8%
Market median
-39% vs market
2020
2024
Equity ratio
46.4%
This company
38.2%
Market median
+21% vs market
2020
2024
Return on equity
25.3%
This company
18.4%
Market median
+38% vs market
2020
2024
Net profit margin
7.4%
This company
8.1%
Market median
-9% vs market
2020
2024
Asset turnover
1.59×
This company
1.12×
Market median
+42% vs market
2020
2024
Debt / equity
1.16×
This company
0.62×
Market median
-87% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-20 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
CN
Cecilie Nilsen
Chief Executive Officer
Chief Executive Officer
2020
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Cecilie Nilsen Holding As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Cecilie Nilsen Holding As
BLODSJEKK AS
(this company)
Board network connections
Board members of BLODSJEKK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Cecilie Nilsen
Chief Executive Officer
0 companies